Oxidative stress is a characteristic of many systemic diseases associated with thrombosis. Thiol isomerases are a family of oxidoreductases important in protein folding and are exquisitely sensitive to the redox environment. They are essential for thrombus formation and represent a previously unrecognized layer of control of the thrombotic process. Yet, the mechanisms by which thiol isomerases function in thrombus formation are unknown.
Recent Advances:
The oxidoreductase activity of thiol isomerases in thrombus formation is controlled by the redox environment via oxidative changes to active site cysteines. Specific alterations can now be detected owing to advances in the chemical biology of oxidative cysteine modifications.
Critical Issues:
Understanding of the role of thiol isomerases in thrombus formation has focused largely on identifying single disulfide bond modifications in isolated proteins (e.g., αIIbβ3, tissue factor, vitronectin, or glycoprotein Ibα [GPIbα]). An alternative approach is to conceptualize thiol isomerases as effectors in redox signaling pathways that control thrombotic potential by modifying substrate networks.
Future Directions:
Cysteine-based chemical biology will be employed to study thiol-dependent dynamics mediated by the redox state of thiol isomerases at the systems level. This approach could identify thiol isomerase-dependent modifications of the disulfide landscape that are prothrombotic.
Get full access to this article
View all access options for this article.
References
1.
AkterS, FuL, JungY, Conte MLo, LawsonJR, LowtherWT, SunR, LiuK, YangJ, and CarrollKS. Chemical proteomics reveals new targets of cysteine sulfinic acid reductase. Nat Chem Biol, 14: 995–1004, 2018.
2.
AlanenHI, SaloKEH, PirneskoskiA, and RuddockLW. pH dependence of the peptide thiol-disulfide oxidase activity of six members of the human protein bisulfide isomerase family. Antioxid Redox Signal, 8: 283–291, 2006.
3.
AlcockLJ, LanginiM, StühlerK, RemkeM, PerkinsMV, BernardesGJL, and ChalkerJM. Proteome-wide survey of cysteine oxidation by using a norbornene probe. ChemBioChem, 21: 1329–1334, 2020.
4.
AnsariSA, PendurthiUR, and RaoLVM. Role of cell surface lipids and thiol-disulphide exchange pathways in regulating the encryption and decryption of tissue factor. Thromb Haemost, 119: 860–870, 2019.
5.
Appenzeller-HerzogC and EllgaardL. In vivo reduction-oxidation state of protein disulfide isomerase: the two active sites independently occur in the reduced and oxidized forms. Antioxid Redox Signal, 10: 55–64, 2008.
6.
BartelsAK, GöttertS, DeselC, SchäferM, KrossaS, ScheidigAJ, GrötzingerJ, and LorenzenI. KDEL receptor 1 contributes to cell surface association of protein disulfide isomerases. Cell Physiol Biochem, 52: 850–868, 2019.
7.
BekendamRH, BendapudiPK, LinL, NagPP, PuJ, KennedyDR, FeldenzerA, ChiuJ, CookKM, FurieB, HuangM, HoggPJ, and FlaumenhaftR. A substrate-driven allosteric switch that enhances PDI catalytic activity. Nat Commun, 7: 12579, 2016.
8.
BekendamRH, IyuD, PassamF, StopaJD, De CeunynckK, MuseO, BendapudiPK, GarnierCL, GopalS, CrescenceL, ChiuJ, FurieB, Panicot-DuboisL, HoggPJ, DuboisC, and FlaumenhaftR. Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation. J Thromb Haemost, 16: 2322–2335, 2018.
9.
BowleySR, FangC, Merrill-SkoloffG, FurieBC, and FurieB. Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation. Nat Commun, 8: 14151, 2017.
10.
BrewerCF and RiehmJP. Evidence for possible nonspecific reactions between N-ethylmaleimide and proteins. Anal Biochem, 18: 248–255, 1967.
11.
BryneLJ, SidhuA, WallisAK, RuddockLW, FreedmanRB, HowardMJ, and WilliamsonRA. Mapping of the ligand-binding site on the b′ domain of human PDI: interaction with peptide ligands and the x-linker region. Biochem J, 423: 209–217, 2009.
12.
BurgessJK, HotchkissKA, SuterC, DudmanNPB, SzöllösiJ, ChestermanCN, ChongBH, and HoggPJ. Physical proximity and functional association of glycoprotein 1bα and protein-disulfide isomerase on the platelet plasma membrane. J Biol Chem, 275: 9758–9766, 2000.
13.
BurnsJA, ButlerJC, MoranJ, and WhitesidesGM. Selective reduction of disulfides by tris(2-carboxyethyl)phosphine. J Org Chem, 56: 2648–2650, 1991.
14.
ButeraD, CookKM, ChiuJ, WongJWH, and HoggPJ. Control of blood proteins by functional disulfide bonds. Blood, 123: 2000–2007, 2014.
15.
ButeraD and HoggPJ. Fibrinogen function achieved through multiple covalent states. Nat Commun, 11: 5468, 2020.
16.
CaoSS and KaufmanRJ. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal, 21: 396–413, 2014.
17.
ChangTS, JeongW, WooHA, SunML, ParkS, and SueGR. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J Biol Chem, 279: 50994–51001, 2004.
18.
ChenF, ZhaoZ, ZhouJ, LuY, EssexDW, and WuY. Protein disulfide isomerase enhances tissue factor-dependent thrombin generation. Biochem Biophys Res Commun, 501: 172–177, 2018.
19.
ChenJ, FuX, WangY, LingM, McMullenB, KulmanJ, ChungDW, and LópezJA. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. Blood, 115: 706–712, 2010.
20.
ChenVM, AhamedJ, VersteegHH, BerndtMC, RufW, and HoggPJ. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry, 45: 12020–12028, 2006.
21.
ChenVM and HoggPJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost, 4: 2533–2541, 2006.
22.
ChenW, ShangWH, AdachiY, HiroseK, FerrariDM, and KamataT. A possible biochemical link between NADPH oxidase (Nox) 1 redox-signalling and ERp72. Biochem J, 416: 55–63, 2008.
23.
ChinnarajM, BarriosDA, FriedenC, HeydukT, FlaumenhaftR, and PozziN. Bioorthogonal chemistry enables single-molecule FRET measurements of catalytically active protein disulfide isomerase. ChemBioChem, 22: 134–138, 2020.
24.
ChinnarajM, FlaumenhaftR, and PozziN. A cysteine-based redox switch regulates millisecond dynamics of protein disulfide isomerase and controls enzyme activity. bioRXiv [Epub ahead of print]; DOI: 10.1101/2020.12.07.414680, 2020.
25.
ChiuJ. Quantification of the redox state of protein disulphide bonds. In: Methods in Molecular Biology, 1st ed., edited by Hogg P. New York, NY: Humana Press, Inc., 2019, pp. 45–63.
26.
ChiuJ and HoggPJ. Allosteric disulfides: sophisticated molecular structures enabling flexible protein regulation. J Biol Chem, 294: 2949–2960, 2019.
27.
ChiuJ, PassamF, ButeraD, and HoggPJ. Protein disulfide isomerase in thrombosis. Semin Thromb Hemost, 41: 765–773, 2015.
28.
ChiversPT, PrehodaKE, and RainesRT. The CXXC motif: a rheostat in the active site. Biochemistry, 36: 4061–4066, 1997.
29.
ChoJ, FurieBC, CoughlinSR, and FurieB. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest, 118: 1123–1131, 2008.
30.
ChoJ, KennedyDR, LinL, HuangM, Merrill-SkoloffG, FurieBC, and FurieB. Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins. Blood, 120: 647–655, 2012.
31.
ClelandWW. Dithiothreitol, a new protective reagent for SH groups. Biochemistry, 3: 480–482, 1964.
32.
Lo Conte M and CarrollKS. Chemoselective ligation of sulfinic acids with aryl-nitroso compounds. Angew Chem Int Ed Engl, 51: 6502–6505, 2012.
33.
Lo Conte M and CarrollKS. The redox biochemistry of protein sulfenylation and sulfinylation. J Biol Chem, 288: 26480–26488, 2013.
34.
Lo ConteM, LinJ, WilsonMA, and CarrollKS. A chemical approach for the detection of protein sulfinylation. ACS Chem Biol, 10: 1825–1830, 2015.
35.
Dalle-DonneI, GiustariniD, ColomboR, MilzaniA, and RossiR. S-glutathionylation in human platelets by a thiol-disulfide exchange-independent mechanism. Free Radic Biol Med, 38: 1501–1510, 2005.
36.
DarbyNJ and CreightonTE. Characterization of the active site cysteine residues of the thioredoxin-like domains of protein disulfide isomerase. Biochemistry, 34: 16770–16780, 1995.
37.
DayalS, GuSX, HutchinsRD, WilsonKM, WangY, FuX, and LentzSR. Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis. Arterioscler Thromb Vasc Biol, 35: 1798–1804, 2015.
38.
DayalS, WilsonKM, MottoDG, MillerFJ, ChauhanAK, and LentzSR. Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation, 127: 1308–1316, 2013.
39.
DenisovAY, MäättänenP, DabrowskiC, KozlovG, ThomasDY, and GehringK. Solution structure of the bb′ domains of human protein disulfide isomerase. FEBS J, 276: 1440–1449, 2009.
40.
DowalL, YangW, FreemanMR, SteenH, and FlaumenhaftR. Proteomic analysis of palmitoylated platelet proteins. Blood, 118: e62–e73, 2011.
ErikssonO, ChiuJ, HoggPJ, AtkinsonJP, LiszewskiMK, FlaumenhaftR, and FurieB. Thiol isomerase ERp57 targets and modulates the lectin pathway of complement activation. J Biol Chem, 294: 4878–4888, 2019.
44.
ErikssonO, StopaJ, and FurieB. Identification of PDI substrates by mechanism-based kinetic trapping. In: Methods in Molecular Biology, 1st ed., edited by Hogg P. New York, NY: Humana Press, Inc., 2019, pp. 165–182.
45.
EssexD and LiM. Redox modification of platelet glycoproteins. Curr Drug Targets, 7: 1233–1241, 2006.
46.
EssexDW. The role of thiols and disulfides in platelet function. Antioxid Redox Signal, 6: 736–746, 2004.
47.
FassD and ThorpeC. Chemistry and enzymology of disulfide cross-linking in proteins. Chem Rev, 118: 1169–1198, 2018.
48.
FernandesDC, WosniakJ, GonçalvesRC, TanakaLY, FernandesCG, ZanattaDB, de MattosABM, StraussBE, and LaurindoFRM. PDIA1 acts as master organizer of NOX1/NOX4 balance and phenotype response in vascular smooth muscle. Free Radic Biol Med, 162: 603–614, 2020.
49.
FlaumenhaftR. Protein disulfide isomerase as an antithrombotic target. Trends Cardiovasc Med, 23: 264–268, 2013.
FlaumenhaftR. Does GPIbα prove the allosteric disulfide bond hypothesis?. J Thromb Haemost, 17: 849–851, 2019.
52.
FlaumenhaftR and FurieB. Vascular thiol isomerases. Blood, 128: 893–901, 2016.
53.
FuX, ChenJ, GallagherR, ZhengY, ChungDW, and LópezJA. Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region. Blood, 118: 5283–5291, 2011.
54.
FurieB and FlaumenhaftR. Thiol isomerases in thrombus formation. Circ Res, 114: 1162–1173, 2014.
55.
GetzEB, XiaoM, ChakrabartyT, CookeR, and SelvinPR. A comparison between the sulfhydryl reductants tris(2-carboxyethyl)phosphine and dithiothreitol for use in protein biochemistry. Anal Biochem, 273: 73–80, 1999.
56.
GilbertHF. Thiol/disulfide exchange equilibria and disulfde bond stability. In: Methods in Enzymology, edited by Packer L. Cambridge, MA: Academic Press, 1995, pp. 8–28.
57.
GimenezM, Veríssimo-FilhoS, WittigI, SchicklingBM, HahnerF, SchürmannC, NettoLES, RosaJC, BrandesRP, SartorettoS, De Lucca CamargoL, AbdulkaderF, MillerFJ, and LopesLR. Redox activation of Nox1 (NADPH oxidase 1) involves an intermolecular disulfide bond between protein disulfide isomerase and p47phox in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 39: 224–236, 2019.
58.
GoYM and JonesDP. Redox theory of aging: implications for health and disease. Clin Sci, 131: 1669–1688, 2017.
59.
GuptaV and CarrollKS. Sulfenic acid chemistry, detection and cellular lifetime. Biochim Biophys Acta, 1840: 847–875, 2014.
60.
GuptaV and CarrollKS. Profiling the reactivity of cyclic C-nucleophiles towards electrophilic sulfur in cysteine sulfenic acid. Chem Sci, 7: 400–415, 2016.
61.
GuptaV, YangJ, LieblerDC, and CarrollKS. Diverse redoxome reactivity profiles of carbon nucleophiles. J Am Chem Soc, 139: 5588–5595, 2017.
62.
HalloranM, ParakhS, and AtkinJD. The role of S-nitrosylation and S-glutathionylation of protein disulphide isomerase in protein misfolding and neurodegeneration. Int J Cell Biol, 2013: 797914, 2013.
63.
HansenRE, ØstergaardH, NørgaardP, and WintherJR. Quantification of protein thiols and dithiols in the picomolar range using sodium borohydride and 4,4′-dithiodipyridine. Anal Biochem, 363: 77–82, 2007.
64.
HawkinsHC and FreedmanRB. The reactivities and ionization properties of the active-site dithiol groups of mammalian protein disulphide-isomerase. Biochem J, 275: 335–339, 1991.
65.
HeinrichTA, Da SilvaRS, MirandaKM, SwitzerCH, WinkDA, and FukutoJM. Biological nitric oxide signalling: chemistry and terminology. Br J Pharmacol, 169: 1417–1429, 2013.
66.
HeppnerDE, DustinCM, LiaoC, HristovaM, VeithC, LittleAC, AhlersBA, WhiteSL, DengB, LamYW, LiJ, and van der VlietA. Direct cysteine sulfenylation drives activation of the Src kinase. Nat Commun, 9: 4522-, 2018.
67.
HiraokaH, NakaharaK, KanekoY, AkiyamaS, OkudaK, IwawakiT, FujimurM, KumagaiY, TakasugiN, and UeharaT. Modulation of unfolded protein response by methylmercury. Biol Pharm Bull, 40: 1595–1598, 2017.
68.
HolbrookLM, KeetonSJ, SasikumarP, NockS, GelzinisJ, BruntE, RyanS, PantosMM, VerbetskyCA, GibbinsJM, and KennedyDR. Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times. Br J Pharmacol, 178: 550–563, 2021.
HolmesAJ and WilliamsDLH. Reaction of ascorbic acid with S-nitrosothiols: clear evidence for two distinct reaction pathways. J Chem Soc Perkin Trans, 2: 1639–1644, 2000.
71.
HotchkissKA, ChestermanCN, and HoggPJ. Catalysis of disulfide isomerization in thrombospondin 1 by protein disulfide isomerase. Biochemistry, 35: 9761–9767, 1996.
72.
HudsonDA, GannonSA, and ThorpeC. Oxidative protein folding: from thiol-disulfide exchange reactions to the redox poise of the endoplasmic reticulum. Free Radic Biol Med, 80: 171–182, 2015.
73.
IgnarroLJ, WoodKS, and WolinMS. Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proc Natl Acad Sci U S A, 79: 2870–2873, 1982.
74.
JaffreySR and SnyderSH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE, 2001: pl1, 2001.
75.
JangJY, MinJH, ChaeYH, BaekJY, Wang SBin, ParkSJ, OhGT, LeeSH, HoYS, and ChangTS. Reactive oxygen species play a critical role in collagen-induced platelet activation via shp-2 oxidation. Antioxid Redox Signal, 20: 2528–2540, 2014.
76.
JasujaR, PassamFH, KennedyDR, KimSH, Van HessemL, LinL, BowleySR, JoshiSS, DilksJR, FurieB, FurieBC, and FlaumenhaftR. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest, 122: 2104–2113, 2012.
77.
JessopCE and BulleidNJ. Glutathione directly reduces an oxidoreductase in the endoplasmic reticulum of mammalian cells. J Biol Chem, 279: 55341–55347, 2004.
78.
JiangXM, FitzgeraldM, GrantCM, and HoggPJ. Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase. J Biol Chem, 274: 2416–2423, 1999.
79.
JonesDP, CarlsonJL, ModyVC, CaiJ, LynnMJ, and SternbergP. Redox state of glutathione in human plasma. Free Radic Biol Med, 28: 625–635, 2000.
80.
JordanPA, StevensJM, HubbardGP, BarrettNE, SageT, AuthiKS, and GibbinsJM. A role for the thiol isomerase protein ERP5 in platelet function. Blood, 105: 1500–1507, 2005.
81.
KallisGB and HolmgrenA. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-32 present in the reduced form of thioredoxin from Escherichia coli. J Biol Chem, 255: 10261–10265, 1980.
82.
KanemuraS, MatsusakiM, InabaK, and OkumuraM. Pdi family members as guides for client folding and assembly. Int J Mol Sci, 21: 9351, 2020.
83.
KaralaAR, LappiAK, and RuddockLW. Modulation of an active-site cysteine pka allows pdi to act as a catalyst of both disulfide bond formation and isomerization. J Mol Biol, 396: 883–892, 2010.
84.
KaralaAR and RuddockLW. Does S-methyl methanethiosulfonate trap the thiol-disulfide state of proteins?. Antioxid Redox Signal, 9: 527–531, 2007.
85.
KarkiP and BirukovKG. Oxidized phospholipids in healthy and diseased lung endothelium. Cells, 9: 981, 2020.
86.
KeLY, LawSH, MishraVK, ParveenF, ChanHC, LuYH, and ChuCS. Molecular and cellular mechanisms of electronegative lipoproteins in cardiovascular diseases. Biomedicines, 8: 550, 2020.
87.
Kenry and LiuB. Bio-orthogonal click chemistry for in vivo bioimaging. Trends Chem, 1: 763–778, 2019.
88.
KimK, HahmE, LiJ, HolbrookLM, SasikumarP, StanleyRG, Ushio-FukaiM, GibbinsJM, and ChoJ. Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice. Blood, 122: 1052–1061, 2013.
89.
KimSO, MerchantK, NudelmanR, BeyerWF, KengT, DeAngeloJ, HausladenA, and StamlerJS. OxyR: a molecular code for redox-related signaling. Cell, 109: 383–396, 2002.
90.
KirschM, BüscherAM, AkerS, SchulzR, and De GrootH. New insights into the S-nitrosothiol-ascorbate reaction. The formation of nitroxyl. Org Biomol Chem, 7: 1954–1962, 2009.
91.
LangerF, SpathB, FischerC, StolzM, AyukFA, KrögerN, BokemeyerC, and RufW. Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. Blood, 121: 2324–2335, 2013.
92.
LappiAK, LensinkMF, AlanenHI, SaloKEH, LobellM, JufferAH, and RuddockLW. A conserved arginine plays a role in the catalytic cycle of the protein disulphide isomerases. J Mol Biol, 335: 283–295, 2004.
93.
LiJ, KimK, JeongSY, ChiuJ, XiongB, PetukhovPA, DaiX, LiX, AndrewsRK, DuX, HoggPJ, and ChoJ. Platelet protein disulfide isomerase promotes glycoprotein Ibα-mediated platelet-neutrophil interactions under thromboinflammatory conditions. Circulation, 139: 1300–1319, 2019.
94.
LiZ, ForshawTE, HolmilaRJ, VanceSA, WuH, PooleLB, FurduiCM, and KingSB. Triphenylphosphonium-derived protein sulfenic acid trapping agents: synthesis, reactivity, and effect on mitochondrial function. Chem Res Toxicol, 32: 526–534, 2019.
95.
LinH, SuX, and HeB. Protein lysine acylation and cysteine succination by intermediates of energy metabolism. ACS Chem Biol, 7: 947–960, 2012.
96.
LinL, GopalS, ShardaA, PassamF, BowleySR, StopaJ, XueG, YuanC, FurieBC, FlaumenhaftR, HuangM, and FurieB. Quercetin-3-rutinoside inhibits protein disulfide isomerase by binding to its b′x domain. J Biol Chem, 290: 23543–23552, 2015.
97.
LindC, GerdesR, HamnellY, Schuppe-KoistinenI, Von LöwenhielmHB, HolmgrenA, and CotgreaveIA. Identification of S-glutathionylated cellular proteins during oxidative stress and constitutive metabolism by affinity purification and proteomic analysis. Arch Biochem Biophys, 406: 229–240, 2002.
98.
LynesEM, BuiM, YapMC, BensonMD, SchneiderB, EllgaardL, BerthiaumeLG, and SimmenT. Palmitoylated TMX and calnexin target to the mitochondria-associated membrane. EMBO J, 31: 457–470, 2012.
99.
MakinoK, OkudaK, SuginoE, NishiyaT, ToyamaT, IwawakiT, FujimuraM, KumagaiY, and UeharaT. Correlation between attenuation of protein disulfide isomerase activity through S-mercuration and neurotoxicity induced by methylmercury. Neurotox Res, 27: 99–105, 2014.
100.
ManuelAM, WallaMD, FaccendaA, MartinSL, TanisRM, PiroliGG, AdamJ, KantorB, MutusB, TownsendDM, and FrizzellN. Succination of protein disulfide isomerase links mitochondrial stress and endoplasmic reticulum stress in the adipocyte during diabetes. Antioxid Redox Signal, 27: 1281–1296, 2017.
101.
MarinoSM and GladyshevVN. Analysis and functional prediction of reactive cysteine residues. J Biol Chem, 287: 4419–4425, 2012.
102.
McGarryDJ, ShchepinovaMM, LillaS, HartleyRC, and OlsonMF. A cell-permeable biscyclooctyne as a novel probe for the identification of protein sulfenic acids. ACS Chem Biol, 11: 3300–3304, 2016.
103.
MetcalfeC, RamasubramoniA, PulaG, HarperMT, MundellSJ, and CoxonCH. Thioredoxin inhibitors attenuate platelet function and thrombus formation. PLoS One, 11: e0163006, 2016.
104.
MezghraniA, FassioA, BenhamA, SimmenT, BraakmanI, and SitiaR. Manipulation of oxidative protein folding and PDI redox state in mammalian cells. EMBO J, 20: 6288–6296, 2001.
105.
MillerYI and ShyyJYJ. Context-dependent role of oxidized lipids and lipoproteins in inflammation. Trends Endocrinol Metab, 28: 143–152, 2017.
106.
MineiroMF, PatricioEdeS, Peixoto ÁS, AraujoTLS, da SilvaRP, MorettiAIS, LimaFS, LaurindoFRM, and MeottiFC. Urate hydroperoxide oxidizes endothelial cell surface protein disulfide isomerase-A1 and impairs adherence. Biochim Biophys Acta Gen Subj, 1864: 129481, 2020.
107.
Mor-CohenR. Disulfide bonds as regulators of integrin function in thrombosis and hemostasis. Antioxid Redox Signal, 24: 16–31, 2016.
108.
MüllerT and WinterD. Systematic evaluation of protein reduction and alkylation reveals massive unspecific side effects by iodine-containing reagents. Mol Cell Proteomics, 16: 1173–1187, 2017.
109.
MustafaAK, GadallaMM, SenN, KimS, MuW, GaziSK, BarrowRK, YangG, WangR, and SnyderSH. HS signals through protein S-sulfhydration. Sci Signal, 2: ra72, 2009.
110.
NalianA and IakhiaevAV. Possible mechanisms contributing to oxidative inactivation of activated protein C: molecular dynamics study. Thromb Haemost, 100: 18–25, 2008.
111.
NardaiG, StadlerK, PappE, KorcsmárosT, JakusJ, and CsermelyP. Diabetic changes in the redox status of the microsomal protein folding machinery. Biochem Biophys Res Commun, 334: 787–795, 2005.
112.
NguyenVD, WallisK, HowardMJ, HaapalainenAM, SaloKEH, SaaranenMJ, SidhuA, WierengaRK, FreedmanRB, RuddockLW, and WilliamsonRA. Alternative conformations of the x region of human protein disulphide-isomerase modulate exposure of the substrate binding b′ domain. J Mol Biol, 383: 1144–1155, 2008.
113.
NichollsP, FitaI, and LoewenPC. Enzymology and structure of catalases. Adv Inorg Chem, 51: 51–106, 2000.
114.
OguraJ, RuddockLW, and ManoN. Cysteine 343 in the substrate binding domain is the primary S-nitrosylated site in protein disulfide isomerase. Free Radic Biol Med, 160: 103–110, 2020.
115.
OkaOBV, YeohHY, and BulleidNJ. Thiol-disulfide exchange between the PDI family of oxidoreductases negates the requirement for an oxidase or reductase for each enzyme. Biochem J, 469: 279–288, 2015.
116.
OkumuraM, KadokuraH, and InabaK. Structures and functions of protein disulfide isomerase family members involved in proteostasis in the endoplasmic reticulum. Free Radic Biol Med, 83: 314–322, 2015.
117.
OkumuraM, NoiK, KanemuraS, KinoshitaM, SaioT, InoueY, HikimaT, AkiyamaS, OguraT, and InabaK. Dynamic assembly of protein disulfide isomerase in catalysis of oxidative folding. Nat Chem Biol, 15: 499–509, 2019.
118.
PassamF, ChiuJ, JuL, PijningA, JahanZ, Mor-CohenR, YeheskelA, KolšekK, ThärichenL, Aponte-SantamaríaC, GräterF, and HoggPJ. Mechano-redox control of integrin de-adhesion. eLife, 7: e34843, 2018.
119.
PassamFH, LinL, GopalS, StopaJD, Bellido-MartinL, HuangM, FurieBC, and FurieB. Both platelet- and endothelial cell-derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis. Blood, 125: 2276–2285, 2015.
120.
PassamFJ and ChiuJ. Allosteric disulphide bonds as reversible mechano-sensitive switches that control protein functions in the vasculature. Biophys Rev, 11: 419–430, 2019.
121.
PaulechJ, SolisN, and CordwellSJ. Characterization of reaction conditions providing rapid and specific cysteine alkylation for peptide-based mass spectrometry. Biochim Biophys Acta, 1834: 372–379, 2013.
122.
PaulsenCE and CarrollKS. Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem Biol, 5: 47–62, 2010.
123.
Peixoto ÁS, GeyerRR, IqbalA, TruzziDR, MorettiAIS, LaurindoFRM, and AugustoO. Peroxynitrite preferentially oxidizes the dithiol redox motifs of protein-disulfide isomerase. J Biol Chem, 293: 1450–1465, 2018.
124.
PengH, ChenW, ChengY, HakunaL, StronginR, and WangB. Thiol reactive probes and chemosensors. Sensors (Basel), 12: 15907–15946, 2012.
125.
PooleTH, ReiszJA, ZhaoW, PooleLB, FurduiCM, and KingSB. Strained cycloalkynes as new protein sulfenic acid traps. J Am Chem Soc, 136: 6167–6170, 2014.
126.
PopleJMM and ChalkerJM. A critical evaluation of probes for cysteine sulfenic acid. Curr Opin Chem Biol, 60: 55–65, 2021.
127.
PuigA, PrimmTP, SurendranR, LeeJC, BallardKD, OrkiszewskiRS, MakarovV, and GilbertHF. A 21-kDa C-terminal fragment of protein-disulfide isomerase has isomerase, chaperone, and anti-chaperone activities. J Biol Chem, 272: 32988–32994, 1997.
128.
RadiR, BeckmanJS, BushKM, and FreemanBA. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem, 266: 4244–4250, 1991.
129.
RamachandranN, RootP, JiangXM, HoggPJ, and MutusB. Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc Natl Acad Sci U S A, 98: 9539–9544, 2001.
130.
ReinhardtC, Von BrühlML, ManukyanD, GrahlL, LorenzM, AltmannB, DlugaiS, HessS, KonradI, OrschiedtL, MackmanN, RuddockL, MassbergS, and EngelmannB. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest, 118: 1110–1122, 2008.
131.
ReynaertNL, CklessK, GualaAS, WoutersEFM, Van Der VlietA, and Janssen-HeiningerYMW. In situ detection of S-glutathionylated proteins following glutaredoxin-1 catalyzed cysteine derivatization. Biochim Biophys Acta, 1760: 380–387, 2006.
132.
RoedeJR, UppalK, LiangY, PromislowDEL, WachtmanLM, and JonesDP. Characterization of plasma thiol redox potential in a common marmoset model of aging. Redox Biol, 1: 387–393, 2013.
133.
RoosG, FoloppeN, and MessensJ. Understanding the pKa of redox cysteines: the key role of hydrogen bonding. Antioxid Redox Signal, 18: 94–127, 2013.
134.
RossiR, GiustariniD, Dalle-DonneI, and MilzaniA. Protein S-glutathionylation and platelet anti-aggregating activity of disulfiram. Biochem Pharmacol, 72: 608–615, 2006.
135.
RuddockLW, HirstTR, and FreedmanRB. pH-dependence of the dithiol-oxidizing activity of DsbA (a periplasmic protein thiol:disulphide oxidoreductase) and protein disulphide-isomerase: studies with a novel simple peptide substrate. Biochem J, 315: 1001–1005, 1996.
136.
SatoY, KojimaR, OkumuraM, HagiwaraM, MasuiS, MaegawaKI, SaikiM, HoribeT, SuzukiM, and InabaK. Synergistic cooperation of PDI family members in peroxiredoxin 4-driven oxidative protein folding. Sci Rep, 3: 2456, 2013.
137.
SaurinAT, NeubertH, BrennanJP, and EatonP. Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc Natl Acad Sci U S A, 101: 17982–17987, 2004.
SchulmanS, BendapudiP, ShardaA, ChenV, Bellido-MartinL, JasujaR, FurieBC, FlaumenhaftR, and FurieB. Extracellular thiol isomerases and their role in thrombus formation. Antioxid Redox Signal, 24: 1–15, 2016.
140.
SchwallerM, WilkinsonB, and GilbertHF. Reduction-reoxidation cycles contribute to catalysis of disulfide isomerization by protein-disulfide isomerase. J Biol Chem, 278: 7154–7159, 2003.
141.
SchwertassekU, WeingartenL, and DickTP. Identification of redox-active cell-surface proteins by mechanism-based kinetic trapping. Sci STKE, 2007: pl8, 2007.
142.
SenaCM, LeandroA, AzulL, SeiçaR, and PerryG. Vascular oxidative stress: impact and therapeutic approaches. Front Physiol, 9: 1668, 2018.
143.
SenisYA, MazharianA, and MoriJ. Src family kinases: at the forefront of platelet activation. Blood, 124: 2013–2024, 2014.
144.
ServeO, KamiyaY, MaenoA, NakanoM, MurakamiC, SasakawaH, YamaguchiY, HaradaT, KurimotoE, Yagi-UtsumiM, IguchiT, InabaK, KikuchiJ, AsamiO, KajinoT, OkaT, NakasakoM, and KatoK. Redox-dependent domain rearrangement of protein disulfide isomerase coupled with exposure of its substrate-binding hydrophobic surface. J Mol Biol, 396: 361–374, 2010.
145.
ShardaA and FurieB. Regulatory role of thiol isomerases in thrombus formation. Expert Rev Hematol, 11: 437–448, 2018.
146.
ShiY and CarrollKS. Activity-based sensing for site-specific proteomic analysis of cysteine oxidation. Acc Chem Res, 53: 20–31, 2020.
147.
SimDS, DilksJR, and FlaumenhaftR. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation. Arterioscler Thromb Vasc Biol, 27: 1478–1485, 2007.
148.
SliskovicI, RaturiA, and MutusB. Characterization of the S-denitrosation activity of protein disulfide isomerase. J Biol Chem, 280: 8733–8741, 2005.
149.
SmithBC and MarlettaMA. Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. Curr Opin Chem Biol, 16: 498–506, 2012.
150.
SonegoG, LeTTM, CrettazD, AbonnencM, TissotJD, and PrudentM. Sulfenylome analysis of pathogen-inactivated platelets reveals the presence of cysteine oxidation in integrin signaling pathway and cytoskeleton regulation. J Thromb Haemost, 19: 233–247, 2021.
151.
StitesWE and FroudeJW. Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?. Med Hypotheses, 68: 811–821, 2007.
152.
StopaJD, BakerKM, GroverSP, FlaumenhaftR, and FurieB. Kinetic-based trapping by intervening sequence variants of the active sites of protein-disulfide isomerase identifies platelet protein substrates. J Biol Chem, 292: 9063–9074, 2017.
153.
StopaJD, NeubergD, PuligandlaM, FurieB, FlaumenhaftR, and ZwickerJI. Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation. JCI Insight, 2: e89373, 2017.
154.
StopaJD and ZwickerJI. The intersection of protein disulfide isomerase and cancer associated thrombosis. Thromb Res, 164(Suppl 1): S130–S135, 2018.
155.
SwiatkowskaM, PadulaG, MichalecL, StasiakM, SkurzynskiS, and CierniewskiCS. Ero1α is expressed on blood platelets in association with protein-disulfide isomerase and contributes to redox-controlled remodeling of αIIbβ3. J Biol Chem, 285: 29874–29883, 2010.
156.
TanakaLY, OliveiraPVS, and LaurindoFRM. Peri/epicellular thiol oxidoreductases as mediators of extracellular redox signaling. Antioxid Redox Signal, 33: 280–307, 2020.
157.
TavenderTJ and BulleidNJ. Molecular mechanisms regulating oxidative activity of the Ero1 family in the endoplasmic reticulum. Antioxid Redox Signal, 13: 1177–1187, 2010.
158.
TejeroJ, ShivaS, and GladwinMT. Sources of vascular nitric oxide and reactive oxygen species and their regulation. Physiol Rev, 99: 311–379, 2019.
159.
ToldoS, BoccellinoM, RinaldiB, SeropianIM, MezzaromaE, SeverinoA, QuagliuoloL, Van TassellBW, MarfellaR, PaolissoG, RossiF, NatarajanR, VoelkelN, AbbateA, CreaF, and BaldiA. Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase. Mol Med, 17: 1012–1021, 2011.
160.
TownsendDM, ManevichY, LinH, YingX, BowersRR, HutchensS, and TewKD. Nitrosative stress-induced S-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response. Cancer Res, 69: 7626–7634, 2009.
161.
WangC, ChenS, WangX, WangL, WallisAK, FreedmanRB, and WangCC. Plasticity of human protein disulfide isomerase: evidence for mobility around the X-linker region and its functional significance. J Biol Chem, 285: 26788–26797, 2010.
162.
WangC, LiW, RenJ, FangJ, KeH, GongW, FengW, and WangCC. Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase. Antioxid Redox Signal, 19: 36–45, 2013.
163.
WangC, YuJ, HuoL, WangL, FengW, and WangCC. Human protein-disulfide isomerase is a redox-regulated chaperone activated by oxidation of domain a′. J Biol Chem, 287: 1139–1149, 2012.
164.
WangK, LiuJQ, ZhongT, LiuXL, ZengY, QiaoX, XieT, ChenY, GaoYY, TangB, LiJ, ZhouJ, PangDW, ChenJ, ChenC, and LiangY. Phase separation and cytotoxicity of tau are modulated by protein disulfide isomerase and S-nitrosylation of this molecular chaperone. J Mol Biol, 432: 2141–2163, 2020.
165.
WangL, WuY, ZhouJ, AhmadSS, MutusB, GarbiN, HämmerlingG, LiuJ, and EssexDW. Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin. Blood, 122: 3642–3650, 2013.
166.
WangL, ZhouJ, WangL, WangC chen, and EssexDW. The b′ domain of protein disulfide isomerase cooperates with the a and a′ domains to functionally interact with platelets. J Thromb Haemost, 17: 371–382, 2019.
167.
WuY, AhmadSS, ZhouJ, WangL, CullyMP, and EssexDW. The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis. Blood, 119: 1737–1746, 2012.
168.
WuY and EssexDW. Vascular thiol isomerases in thrombosis: the yin and yang. J Thromb Haemost, 18: 2790–2800, 2020.
169.
XiaoR, Lundström-LjungJ, HolmgrenA, and GilbertHF. Catalysis of thiol/disulfide exchange. J Biol Chem, 280: 21099–21106, 2005.
170.
XiongB, JhaV, MinJK, and ChoJ. Protein disulfide isomerase in cardiovascular disease. Exp Mol Med, 52: 390–399, 2020.
171.
YangM, LiW, HarbergC, ChenW, YueH, FerreiraRB, Wynia-SmithSL, CarrollKS, ZielonkaJ, FlaumenhaftR, SilversteinRL, and SmithBC. Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia. Blood Adv, 4: 4494–4507, 2020.
172.
YangM and SilversteinRL. CD36 signaling in vascular redox stress. Free Radic Biol Med, 136: 159–171, 2019.
173.
YangS, WangX, CuiL, DingX, NiuL, YangF, WangC, WangC, and LouJ. Compact conformations of human protein disulfide isomerase. PLoS One, 9: e103472, 2014.
174.
YueY, HuoF, LeeS, YinC, and YoonJ. A review: the trend of progress about pH probes in cell application in recent years. Analyst, 142: 30–41, 2017.
175.
ZaiA, RuddMA, ScribnerAW, and LoscalzoJ. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest, 103: 393–399, 1999.
176.
ZhaoZ, WuY, ZhouJ, ChenF, YangA, and EssexDW. The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses. Blood, 133: 246–251, 2019.
177.
ZhouJ, WuY, ChenF, WangL, RauovaL, HayesVM, PonczM, LiH, LiuT, LiuJ, and EssexDW. The disulfide isomerase ERp72 supports arterial thrombosis in mice. Blood, 130: 817–828, 2017.
178.
ZhouJ, WuY, WangL, RauovaL, HayesVM, PonczM, and EssexDW. The C-terminal CGHC motif of protein disulfide isomerase supports thrombosis. J Clin Invest, 125: 4391–4406, 2015.
179.
ZwickerJI, SchlechterBL, StopaJD, LiebmanHA, AggarwalA, PuligandlaM, CaugheyT, BauerKA, KuemmerleN, WongE, WunT, McLaughlinM, HidalgoM, NeubergD, FurieB, and FlaumenhaftR. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI Insight, 4: e125851, 2019.
